{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:28:32Z","timestamp":1788316112522,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002657","name":"Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["2023\/500"],"award-info":[{"award-number":["2023\/500"]}],"id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.prp.2023.155075","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T11:49:10Z","timestamp":1704196150000},"page":"155075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing"],"prefix":"10.1016","volume":"254","author":[{"given":"Seref Bugra","family":"Tuncer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda Kilic","family":"Erciyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge Sukruoglu","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busra Kurt","family":"G\u00fcltaslar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demet Akdeniz","family":"Odemis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukaddes","family":"Avsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0131nar Mualla","family":"Saip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulya","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.prp.2023.155075_bib1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/ijc.34002","article-title":"Ovarian cancer today and tomorrow: a global assessment by world region and Human Development Index using GLOBOCAN 2020","volume":"151","author":"Cabasag","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.155075_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2478\/jomb-2018-0037","article-title":"Novel associations between BRCA1 variants C.181 T>G (Rs28897672) and ovarian crisk in Saudi females","volume":"38","author":"Alyahri","year":"2019","journal-title":"J. Med. Biochem."},{"issue":"3","key":"10.1016\/j.prp.2023.155075_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5152\/ejbh.2019.4890","article-title":"Breast cancer in Turkey; an analysis of 20.000 patients with breast cancer","volume":"15","author":"Ozmen","year":"2019","journal-title":"Eur. J. Breast Health"},{"issue":"9","key":"10.1016\/j.prp.2023.155075_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc.2016.72","article-title":"Hereditary breast and ovarian cancer: new genes in confined pathways","volume":"16","author":"Nielsen","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"5182","key":"10.1016\/j.prp.2023.155075_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.prp.2023.155075_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100235","article-title":"Impact of deleterious variants in other genes beyond BRCA1\/2 detected in breast\/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge","volume":"6","author":"Bono","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.prp.2023.155075_bib7","first-page":"27","article-title":"Spectrum and prevalence of BRCA1\/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study","volume":"17","author":"Rashid","year":"2019","journal-title":"Hered. Cancer Clin. Pr."},{"issue":"1","key":"10.1016\/j.prp.2023.155075_bib8","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/bcr2832","article-title":"Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1\/2-founder mutation-negative breast and\/or ovarian cancer individuals","volume":"13","author":"Kuusisto","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2023.155075_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41523-017-0024-8","article-title":"The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk","volume":"3","author":"Slavin","year":"2017","journal-title":"NPJ Breast Cancer"},{"issue":"7","key":"10.1016\/j.prp.2023.155075_bib10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","article-title":"Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment","volume":"1","author":"Desmond","year":"2015","journal-title":"JAMA Oncol."},{"issue":"28","key":"10.1016\/j.prp.2023.155075_bib11","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.1073\/pnas.1007983107","article-title":"Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing","volume":"107","author":"Walsh","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.prp.2023.155075_bib12","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.6004\/jnccn.2018.0083","article-title":"Breast cancer screening and diagnosis, version 3.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Bevers","year":"2018","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"10.1016\/j.prp.2023.155075_bib13","unstructured":"[The Helsinki Declaration of the World Medical Association (WMA). Ethical principles of medical research involving human subjects]. Pol Merkur Lekarski, 2014. 36(215): p. 298\u2013301."},{"issue":"10","key":"10.1016\/j.prp.2023.155075_bib14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","article-title":"NCCN guidelines(R) insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024.","volume":"21","author":"Daly","year":"2023","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"10.1016\/j.prp.2023.155075_bib15","unstructured":"Network, N.C.C. Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic (Version: 3.2023). February 13, 2023]; Available from: \u3008https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bop.pdf\u3009."},{"key":"10.1016\/j.prp.2023.155075_bib16","first-page":"208","article-title":"Clinical application of multigene panels: challenges of next-generation counseling and cancer risk management","volume":"5","author":"Slavin","year":"2015","journal-title":"Front Oncol."},{"issue":"13","key":"10.1016\/j.prp.2023.155075_bib17","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer","volume":"34","author":"Tung","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2023.155075_bib18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ygyno.2018.09.030","article-title":"Germline pathogenic variants identified in women with ovarian tumors","volume":"151","author":"Carter","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2023.155075_bib19","doi-asserted-by":"crossref","first-page":"bar030","DOI":"10.1093\/database\/bar030","article-title":"Ensembl BioMarts: a hub for data retrieval across taxonomic space","volume":"2011","author":"Kinsella","year":"2011","journal-title":"Database"},{"issue":"1","key":"10.1016\/j.prp.2023.155075_bib20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/s12864-019-5957-x","article-title":"Evaluating the quality of the 1000 genomes project data","volume":"20","author":"Belsare","year":"2019","journal-title":"BMC Genom."},{"issue":"1","key":"10.1016\/j.prp.2023.155075_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13073-017-0403-7","article-title":"Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation","volume":"9","author":"Kobayashi","year":"2017","journal-title":"Genome Med"},{"issue":"8","key":"10.1016\/j.prp.2023.155075_bib22","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/humu.24309","article-title":"Variant interpretation using population databases: lessons from gnomAD","volume":"43","author":"Gudmundsson","year":"2022","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.prp.2023.155075_bib23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1101\/gr.212802","article-title":"Accounting for human polymorphisms predicted to affect protein function","volume":"12","author":"Ng","year":"2002","journal-title":"Genome Res."},{"key":"10.1016\/j.prp.2023.155075_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/0471142905.hg0720s76","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","author":"Adzhubei","year":"2013","journal-title":"Curr. Protoc. Hum. Genet"},{"issue":"8","key":"10.1016\/j.prp.2023.155075_bib25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat. Methods"},{"issue":"D1","key":"10.1016\/j.prp.2023.155075_bib26","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.prp.2023.155075_bib27","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","article-title":"The human gene mutation database (HGMD((R))): optimizing its use in a clinical diagnostic or research setting","volume":"139","author":"Stenson","year":"2020","journal-title":"Hum. Genet."},{"issue":"5","key":"10.1016\/j.prp.2023.155075_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"issue":"1","key":"10.1016\/j.prp.2023.155075_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13073-023-01199-y","article-title":"ClinVar and HGMD genomic variant classification accuracy has improved over time, as measured by implied disease burden","volume":"15","author":"Sharo","year":"2023","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.prp.2023.155075_bib30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2023.155075_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cancergen.2019.10.004","article-title":"Clinicopathologic features and genetic characteristics of the BRCA1\/2 mutation in Turkish breast cancer patients","volume":"240","author":"Cecener","year":"2020","journal-title":"Cancer Genet"},{"key":"10.1016\/j.prp.2023.155075_bib32","volume":"2","author":"Nielsen","year":"2018","journal-title":"JCO Precis Oncol."},{"issue":"Suppl 5","key":"10.1016\/j.prp.2023.155075_bib33","doi-asserted-by":"crossref","first-page":"v20","DOI":"10.1093\/annonc\/mdq161","article-title":"BRCA in breast cancer: ESMO clinical practice guidelines","volume":"21","author":"Balmana","year":"2010","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2023.155075_bib34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.ejhg.5200652","article-title":"BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients","volume":"9","author":"Sarantaus","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.prp.2023.155075_bib35","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0959-8049(00)00110-6","article-title":"Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer","volume":"36","author":"Anton-Culver","year":"2000","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.155075_bib36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9378(98)70476-4","article-title":"BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing","volume":"178","author":"Rubin","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.prp.2023.155075_bib37","first-page":"2433","article-title":"Frequency of germline and somatic BRCA1 mutations in ovarian cancer","volume":"4","author":"Berchuck","year":"1998","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.prp.2023.155075_bib38","first-page":"2738","article-title":"Mutations of the BRCA2 gene in ovarian carcinomas","volume":"56","author":"Takahashi","year":"1996","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2023.155075_bib39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ejhg.2010.203","article-title":"On the origin and diffusion of BRCA1c.5266dupC (5382insC) in European populations","volume":"19","author":"Hamel","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.prp.2023.155075_bib40","first-page":"468","article-title":"Analysis of several BRCA1 and BRCA2 mutations in a hospital-based series of unselected breast cancer cases","volume":"108","author":"Burcos","year":"2013","journal-title":"Chirurgia"},{"issue":"2","key":"10.1016\/j.prp.2023.155075_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ygyno.2007.09.035","article-title":"High frequency of BRCA1\/2 germline mutations in consecutive ovarian cancer patients in Poland","volume":"108","author":"Brozek","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2023.155075_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2193-1801-1-20","article-title":"BRCA1 And BRCA2 analysis of Argentinean breast\/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin","volume":"1","author":"Solano","year":"2012","journal-title":"Springerplus"},{"issue":"3","key":"10.1016\/j.prp.2023.155075_bib43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","article-title":"Founder BRCA1\/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control","volume":"1","author":"Janavicius","year":"2010","journal-title":"EPMA J."},{"issue":"7","key":"10.1016\/j.prp.2023.155075_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201086","article-title":"BRCA1 founder mutations and beyond in the Polish population: a single-institution BRCA1\/2 next-generation sequencing study","volume":"13","author":"Kowalik","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.prp.2023.155075_bib45","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/humu.23842","article-title":"The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries","volume":"40","author":"Laitman","year":"2019","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.prp.2023.155075_bib46","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s10549-012-2159-5","article-title":"Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer","volume":"134","author":"Kim","year":"2012","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"10.1016\/j.prp.2023.155075_bib47","first-page":"7","article-title":"Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon","volume":"10","author":"Jalkh","year":"2012","journal-title":"Hered. Cancer Clin. Pr."},{"issue":"2","key":"10.1016\/j.prp.2023.155075_bib48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cancergencyto.2006.05.005","article-title":"RNA-based analysis of BRCA1 and BRCA2 gene alterations","volume":"170","author":"Bonatti","year":"2006","journal-title":"Cancer Genet. Cytogenet."},{"issue":"10","key":"10.1016\/j.prp.2023.155075_bib49","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/jmg.2004.029538","article-title":"Splicing in action: assessing disease causing sequence changes","volume":"42","author":"Baralle","year":"2005","journal-title":"J. Med. Genet."},{"issue":"3","key":"10.1016\/j.prp.2023.155075_bib50","doi-asserted-by":"crossref","first-page":"E1200","DOI":"10.1002\/humu.21202","article-title":"Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study","volume":"31","author":"Borg","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.prp.2023.155075_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2017.10.002","article-title":"Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center","volume":"220","author":"Apessos","year":"2018","journal-title":"Cancer Genet."},{"issue":"2","key":"10.1016\/j.prp.2023.155075_bib52","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jmoldx.2014.11.004","article-title":"Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and\/or ovarian cancer","volume":"17","author":"Trujillano","year":"2015","journal-title":"J. Mol. Diagn."},{"issue":"1","key":"10.1016\/j.prp.2023.155075_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1515\/tjb-2019-0424","article-title":"Spectrum of BRCA1\/BRCA2 variants in 1419 Turkish breast and ovarian cancer patients: a single center study","volume":"45","author":"Bahsi","year":"2019","journal-title":"Turk. J. Biochem."},{"issue":"5","key":"10.1016\/j.prp.2023.155075_bib54","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/hmg\/7.5.801","article-title":"The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim","volume":"7","author":"Bar-Sade","year":"1998","journal-title":"Hum. Mol. Genet"},{"issue":"4","key":"10.1016\/j.prp.2023.155075_bib55","doi-asserted-by":"crossref","first-page":"R284","DOI":"10.1186\/bcr785","article-title":"The Icelandic founder mutation BRCA2 999del5: analysis of expression","volume":"6","author":"Mikaelsdottir","year":"2004","journal-title":"Breast Cancer Res."},{"issue":"10","key":"10.1016\/j.prp.2023.155075_bib56","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/onc.2015.181","article-title":"Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations","volume":"35","author":"Golmard","year":"2016","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.prp.2023.155075_bib57","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/j.febslet.2010.05.031","article-title":"Multiple roles of ATM in monitoring and maintaining DNA integrity","volume":"584","author":"Derheimer","year":"2010","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.prp.2023.155075_bib58","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/ijc.32385","article-title":"Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer","volume":"145","author":"Kleiblova","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.155075_bib59","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/cam4.1376","article-title":"Gene panel testing of 5589 BRCA1\/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer","volume":"7","author":"Hauke","year":"2018","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.prp.2023.155075_bib60","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/jmedgenet-2015-103398","article-title":"Multigene testing of moderate-risk genes: be mindful of the missense","volume":"53","author":"Young","year":"2016","journal-title":"J. Med Genet"},{"issue":"16","key":"10.1016\/j.prp.2023.155075_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164154","article-title":"Gene panel testing for breast cancer reveals differential effect of prior BRCA1\/2 probability","volume":"13","author":"Evans","year":"2021","journal-title":"Cancers"},{"issue":"15","key":"10.1016\/j.prp.2023.155075_bib62","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1200\/JCO.18.01854","article-title":"Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients","volume":"37","author":"Kurian","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2023.155075_bib63","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/cas.14313","article-title":"Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer","volume":"111","author":"Lin","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2023.155075_bib64","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41439-020-0089-z","article-title":"A novel nonsense mutation of ERCC2 in a Vietnamese family with xeroderma pigmentosum syndrome group D","volume":"7","author":"Bui","year":"2020","journal-title":"Hum. Genome Var."},{"issue":"4","key":"10.1016\/j.prp.2023.155075_bib65","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ijc.21931","article-title":"Evaluation of xeroderma pigmentosum XPA, XPC, XPD, XPF, XPB, XPG and DDB2 genes in familial early-onset lung cancer predisposition","volume":"119","author":"Matakidou","year":"2006","journal-title":"Int J. Cancer"},{"issue":"8","key":"10.1016\/j.prp.2023.155075_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006248","article-title":"Identification and functional testing of ERCC2 mutations in a multi-national Cohort of patients with familial breast- and ovarian cancer","volume":"12","author":"Rump","year":"2016","journal-title":"PLoS Genet"},{"issue":"7","key":"10.1016\/j.prp.2023.155075_bib67","doi-asserted-by":"crossref","first-page":"428","DOI":"10.5306\/wjco.v11.i7.428","article-title":"MUTYH: not just polyposis","volume":"11","author":"Curia","year":"2020","journal-title":"World J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.155075_bib68","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026252","article-title":"TP53 mutations in breast and ovarian cancer","volume":"7","author":"Silwal-Pandit","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.prp.2023.155075_bib69","doi-asserted-by":"crossref","first-page":"19986","DOI":"10.1038\/s41598-019-55515-x","article-title":"Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients","volume":"9","author":"Jarhelle","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.155075_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41439-021-00140-2","article-title":"Germline mutational spectrum in Armenian breast cancer patients suspected of hereditary breast and ovarian cancer","volume":"8","author":"Moradian","year":"2021","journal-title":"Hum. Genome Var."},{"key":"10.1016\/j.prp.2023.155075_bib71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41523-020-0163-1","article-title":"Prevalence of disease-causing genes in Japanese patients with BRCA1\/2-wildtype hereditary breast and ovarian cancer syndrome","volume":"6","author":"Kaneyasu","year":"2020","journal-title":"NPJ Breast Cancer"},{"issue":"11","key":"10.1016\/j.prp.2023.155075_bib72","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","article-title":"Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes","volume":"22","author":"Castera","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"issue":"29","key":"10.1016\/j.prp.2023.155075_bib73","doi-asserted-by":"crossref","first-page":"47064","DOI":"10.18632\/oncotarget.16791","article-title":"Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer","volume":"8","author":"Tedaldi","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.prp.2023.155075_bib74","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2019.01.027","article-title":"Large-scale meta-analysis of mutations identified in panels of breast\/ovarian cancer-related genes - providing evidence of cancer predisposition genes","volume":"153","author":"Suszynska","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2023.155075_bib75","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fgene.2019.01005","article-title":"Exome sequencing in BRCA1- and BRCA2-negative Greek families identifies MDM1 and NBEAL1 as candidate risk genes for hereditary breast cancer","volume":"10","author":"Glentis","year":"2019","journal-title":"Front Genet."},{"issue":"1","key":"10.1016\/j.prp.2023.155075_bib76","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamaoncol.2018.2956","article-title":"Association of breast and ovarian cancers with predisposition genes identified by large-scale sequencing","volume":"5","author":"Lu","year":"2019","journal-title":"JAMA Oncol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823007768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823007768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T08:02:04Z","timestamp":1767168124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823007768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":76,"alternative-id":["S0344033823007768"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.155075","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.155075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155075"}}